info@pharmacyconsulting.co.uk

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
NIMAR – The list was updated 21.12.2022

NIMAR – The list was updated 21.12.2022

by Ryan Watts | Dec 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

NIMAR – The list was updated 21.12.2022

NIMAR – The list is getting longer…

by Sally Finlayson | Nov 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

Are you decommissioning products with the correct status?

Are you decommissioning products with the correct status?

by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP

The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

he UK MAs currently cover the whole of the “UK” so the UK MAs include Northern Ireland Supply…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

Lets start with the definition GB is now only…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in Northern Ireland (NI) need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

For Northern Irish Pharmacies FMD requirements have not changed and they must continue to verify and decommission their “2D” barcoded packs…

« Older Entries

Recent Posts

  • Minister responsible for Pharmacy announced
  • Heatwaves, Medicines and the Leadership Imperative
  • Climate Change Is Creating a New Challenge for Medicines Storage

Upcoming Courses

  • Introduction to Good Distribution Practice Online Training on 16 October 2026 10:00 am
  • GDP Audit Online Training on 19 October 2026 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 20 October 2026
  • Intro to the Responsible Person (import) Role (Online) on 23 October 2026
  • Introduction to Good Distribution Practice Online Training on 4 November 2026 10:00 am

MHRA Alerts & Recalls

Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014
13 October 2026
Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42
12 October 2026
Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013
9 October 2026
Field Safety Notices for October 2026
9 October 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: info@pharmacyconsulting.co.uk
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow